Racura Oncology LtdASX: RAC

Pre-IND Meeting Confirms 505(b)(2) Pathway for Bisantrene

Feb 16, 2017 at 4:09 AM UTC · Issued by Racura Oncology Ltd

Race Oncology Ltd has released a press release.

View Attachment